Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    "desmoid tumor"
Show Display Options
RSS Create an RSS feed from your search for:
"desmoid tumor"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Toremifene in Treating Patients With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: toremifene;   Procedure: conventional surgery
2 Completed Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: methotrexate;   Drug: vinblastine sulfate
3 Recruiting PAZOPANIB Efficacy and Tolerance in Desmoids Tumors
Condition: Progressive Desmoids Tumors
Interventions: Drug: PAZOPANIB treatment;   Drug: Active Comparator: Vinblastine and Methotrexate
4 Completed Radiation Therapy in Treating Patients With Aggressive Fibromatoses
Condition: Desmoid Tumor
Intervention: Radiation: radiation therapy
5 Active, not recruiting
Has Results
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Condition: Desmoid Tumor
Interventions: Drug: tamoxifen citrate;   Drug: sulindac;   Other: laboratory biomarker analysis
6 Recruiting Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment
Condition: Desmoid Tumors
Intervention: Device: "cryoprobes"
7 Active, not recruiting Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Conditions: Desmoid Tumors;   Aggressive Fibromatosis
Intervention: Drug: PF-03084014
8 Recruiting A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Condition: Desmoid Tumor
Intervention: Drug: Sirolimus
9 Active, not recruiting Study to Evaluate Imatinib in Desmoid Tumors
Conditions: Aggressive Fibromatosis;   Desmoid Tumor
Intervention: Drug: Imatinib
10 Recruiting 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions: Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous Polyposis
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
11 Withdrawn Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Conditions: Desmoid Tumors;   Fibromatosis
Intervention: Drug: Hydroxyurea
12 Completed Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
Condition: Desmoid Tumor
Intervention: Drug: imatinib mesylate
13 Active, not recruiting Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Conditions: Advanced Desmoid Tumor;   Advanced Chondrosarcoma
Intervention: Drug: Imatinib Mesylate
14 Recruiting National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
Condition: Aggressive Fibromatosis
Interventions: Procedure: biopsy;   Other: biobank constitution;   Procedure: Coloscopy;   Procedure: Blood sampling (facultative);   Other: Pain evaluation;   Procedure: Tumor biobank realization
15 Recruiting Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Condition: Desmoid Type-fibromatosis
Intervention: Drug: Toremifene
16 Recruiting Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Condition: Desmoid-type Fibromatosis
Intervention: Other: Observational approach
17 Active, not recruiting Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Desmoid-Type Fibromatosis
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sorafenib Tosylate
18 Recruiting Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors
Conditions: The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an;   Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After;   Surgical Resection
Intervention: Drug: 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
19 Completed A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
Conditions: Gardner Syndrome;   Colorectal Carcinoma;   Desmoid Tumor
Intervention:
20 Temporarily not available Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
Conditions: Neoplasm;   Desmoid Tumor
Intervention: Drug: PF-03084014

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.